The Neurocognitive Profile: A High Efficiency Integrated Brain-Behavior Assay

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$400,000.00
Award Year:
2007
Program:
SBIR
Phase:
Phase I
Contract:
1R43MH078436-01A1
Award Id:
85866
Agency Tracking Number:
MH078436
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
ADVANCED BRAIN MONITORING, INC., 2237 FARADAY AVE, SUITE 100, CARLSBAD, CA, 92008
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
969842715
Principal Investigator:
CHRIS BERKA
(760) 720-0099
CHRIS@B-ALERT.COM
Business Contact:
CHRIS BERKA
() -
chris@b-alert.com
Research Institute:
n/a
Abstract
DESCRIPTION (provided by applicant): Alterations in neurocognitive function play a major role in numerous sleeps, neurological and psychiatric disorders and can have a significant impact on quality of life, treatment efficacy, rehabilitation and ability to function at work and in normal daily activities. The methods currently available for neurocognitive investigations including traditional neuropsychological assessment (e.g. Halstead-Reitan, Wechsler memory battery), neurophysiological measures (e.g. ele ctroencephalogram, Multiple Sleep Latency Test) and behavioral tests (e.g. Continuous Performance Test, Psychomotor Vigilance Test) are time-consuming, expensive and often require substantial technical expertise to administer and interpret. The Alertness a nd Memory Profiling (AMP) system integrates neurophysiological, behavioral and subjective measures in a platform designed for quantitative assessment of neurocognitive functions including alertness, attention, learning and memory. The AMP employs a multiva riate approach, combining EEG, neuropsychological tests and validated self-report inventories in an easy-to-administer set of protocols. Initial investigations revealed that AMP could be used to characterize the changes in alertness, learning and memory as sociated with sleep deprivation in healthy subjects and to provide a biobehavioral assay that identified those Individuals most and least susceptible to the effects of sleep deprivation. The AMP also proved sensitive and specific in discriminating patie nts with the highly prevalent, under-diagnosed Obstructive Sleep Apnea (OSA) from healthy subjects. The AMP characterized individual profiles of alertness and memory impairment and quantified the amelioration of some cognitive impairments following treatme nt with CPAP. Four neurocognitive factors were derived from the AMP data: sustained attention, processing speed, verbal memory and visuospatial memory. Preliminary investigations with the AMP prototype systems have resulted in inquiries from a wide range of researchers and clinicians interested in applying the AMP to investigations in sleep medicine, drug addiction, pharmaceutical evaluation, forensic investigations, ergonomics, sports medicine, military applications, education/training evaluations, and oc cupational medicine. The plan for the Phase I is to build upon this foundation of work in the area of sleep medicine, and extend the development of AMP platform to accommodate the range of potential applications and to take the next step in the evolution o f the AMP product in a clinical applications study in collaboration with the New York University sleep laboratory.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government